-Dow Jones
Recap: Evogene Q4 Earnings
Evogene (NASDAQ:EVGN) reported its Q4 earnings results on Thursday, March 10, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Related Posts
Epizyme Granted FDA Orphan Designation For Treatment Of Multiple Myeloma
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=857121
Barclays Maintains Overweight on Chubb, Lowers Price Target to $249
Barclays analyst Tracy Benguigui maintains Chubb (NYSE:CB) with a Overweight and lowers the price target from $250 to $249.